4/17/14
Objec ves ● Recognize main divisions of plant and fungal Introduc on to taxonomic groups. ● Iden fy various examples of herbals and Herbal Medicine associated organic compounds. ● Discuss main issues concerning herbal medicine Jason Schoneman MA, RN use in United States. The University of Texas at Aus n ● Examine current research surrounding medicinal
http://www.mexicolore.co.uk/aztecs/health Cannabis.
Objec ves ● Discuss history and role of psychedelic herbs in medicine and illness. ● List herbs used as legal and illicit drugs of Plantae abuse. ● Associate main plant and fungal families with representa ve poisonous compounds. ● Discuss clinical management of main toxic
http://scienceblogs.com/evolgen/2007/07/06/phylogeny- compounds. friday-06-july-2007/
Algae Bryophytes Brown algae Green algae Moss
http://ucommphoto.nmsu.edu http://en.wikipedia.org/wiki/Algae www.botany.ubc.ca/bryophyte
1 4/17/14
Pteridophytes Ferns
Gymnosperms
Conifers Cycads Microcycas calocoma Cunninghamia sp. Taxodium distichum
Ginkgo Gnetophyta
Ginkgo biloba
Ephedra sinica
http://en.wikipedia.org/wiki/Ginkgo_biloba
http://en.wikipedia.org/wiki/Ephedra
2 4/17/14
Angiosperms Palms Monocots Copernicia baileyana
Sedges Bananas Cladium sp. Musa sp.
Bromeliads Aroids Bromeliaceae Amorphophallus tanum
http://abrimaal.pro-e.pl/araceum/amorphophallus/titanum.htm
3 4/17/14
Angiosperms Oaks Dicots Quercus sp.
Cac Hibiscus Hylocereus sp. Hibiscus coccineus
Pitcher plant Fungi Nepenthes sp.
http://sharonapbio-taxonomy.wikispaces.com/Fungi
4 4/17/14
Main Groups of Fungi
● Zygomycetes (Bread molds) Ascomycetes ● Ascomycetes (Sac fungi) ● Basidiomycetes (Club fungi, “mushrooms”) Sac fungi
Aspergillus sp. Ergot fungi Claviceps purpurea
http://wpr.staff.ipb.ac.id/ http://en.wikipedia.org/wiki/Claviceps_purpurea
Morel Basidiomycetes Morchella sp. Club fungi
http://foragesouth.wordpress.com/tag/morel-mushrooms/
5 4/17/14
Fly agaric Panaeolus sp. Amanita muscaria
http://theergot.wordpress.com/2013/08/03/lets-get-excited-about- Schultes et al., 1992 shrooms/
Carbohydrates
● Cellulose (fiber) Main Organic Herbal ● Mycopolysaccharides: ○ Beta-glucans are the medicinal compounds in Compounds fungi and affect every area of the body.
Shitake Len nula edodes
China http://www.silversageherbs.com/zencart/index.php? main_page=product_info&products_id=334
6 4/17/14
Lipids Lipids ● Fa y acids (carbon chains with single carboxyl ● Alpha-linolenic acid (omega-3 polyunsaturated radical): ○ Palm fa y acids): ○ Olive ○ Flaxseed (Linum usita ssimum) ● Gamma-linolenic acid (omega-6 polyunsaturated ● Hydrocarbon sulfides: fa y acids): ○ Garlic (Allium sa vum) ○ Evening primrose (Oenethera binennis) ■ produces allicin with many medicinal values ○ Hemp (Cannabis sp.) ■ odiferous ○ Borage (Borago officinalis)
Omega-6
Olive Olea europaea
http://www.visionsmartcenter.com/information/16/GLA-Gamma%20Linolenic%20Acid
Evening Flaxseed primrose Linum usita ssimum Oenethera binennis
http://www.ag.ndsu.edu/agnic/flax/wales%203.htm http://en.wikipedia.org/wiki/Oenothera
7 4/17/14
Terpenes ● Aroma c hydrocarbons: ○ backbone isoprene units (C5H8) Garlic ● Most numerous secondary plant compounds Allium sa vum ● Monoterpenes-essen al oils: ○ Lamiaceae (Mentha) ○ Pinaceae (Pinus) ○ Rutaceae (Citrus) http://tinyfarmblog.com/garlic-for-sale/
Terpenes ● Sesquiterpene lactones: ○ Artemesia annua ● Diterpenes: ○ Salvinorin A (Salvia divinorum) ○ Ginkgolide A (Ginkgo biloba)
http://science.uvu.edu/ochem/index.php/alphabetical/s-t/terpenes/
Saponins
● Soap-like compounds (amphipathic glycosides) Artemesia ● Steroid saponins: Artemesia annua ○ Diosgenin (Dioscorea) ■ precursor for progesterone forma on ○ Ginsenoside Re (Panax ginseng)
http://www.mswn.com/plants/database/plant/artemisia-frigida/
8 4/17/14
Saponins ● Cardiac glycosides: ○ Oleander (Nerium) ○ Foxglove (Digitalis sp.) ● Tetraterpeniods: ○ carotenes ○ xanthophylls
○ re noids https://www.standardprocess.com/Products/MediHerb/Wild-Yam-12 ○ colors=an oxidants
Wild Yam Dioscorea sp. Foxglove Digitalis purpurea
http://www.cnseed.org/purple-foxglove-digitalis-purpurea.html https://www.standardprocess.com/Products/MediHerb/Wild-Yam-12
Polyphenols Polyphenols ● Quinones: ● Made up of mul ple phenol types ○ Sennoside A (Senna alexandrina) ○ (C6H5OH)-aroma c benzene ring ○ Hypericin ● Simple phenols and phenolic acids: ■ (“St. John’s Wort”Hypericum perforatum) ○ Salicin (Salix sp.) ● S lbenoids: ○ Delta-9-tetracannabinol (Cannabis sp.) ○ Resveratrol (Vi s vinifera) ○ Vanillin (Vanilla planifolia) ● Flavonoids: ○ anthocyanins=colors=an oxidants
9 4/17/14
Willow Salix sp.
http://www.mdidea.net/products/herbextract/salicin/data02.html
http://en.wikipedia.org/wiki/Salix_alba
Senna Vanilla Senna alexandrina Vanilla planifolia
http://botanical.com/botanical/mgmh/s/senna-42.html
● Piperidine: Alkaloids Alkaloids ● Purine: ○ Tobacco (Nico ana sp.) ○ Methylxanthines ● B-carboline: ■ Caffeine: Coffea, Ilex paraguariensis, Cola ○ Harmaline (Passiflora sp.) acuminata ○ Mescaline (Lophophora, Echinopsis) ■ Caffeine, theobromine: Theobroma cacao ○ Muscimol (Amanita muscaria) ■ Caffeine, theophylline: Camellia sinensis ○ Psilocybin (“magic mushrooms”) ● Isoquinoline: ○ Vinblas ne and Vincris ne (Catharanthus ○ Morphine, codeine (Papaver somniferum) roseus–Madagascar periwinkle)
10 4/17/14
Alkaloids Alkaloids ● Indole: ● Tropane (an cholinergics): ○ Ergot (Claviceps sp.) ○ Atropine,Hyoscyamine, Scopolamine (Atropa ○ d-cathine (Catha edulis) belladonna, Datura, Brugmansia, Mandragora ○ l-ephedrine, d-pseudoephedrine (Ephedra sp.) officinarum) ● Quinoline: ○ Tubocurare (Chondrodendron tomentosum) ○ Quinine (Cinchona officinalis) ○ Coca & Cocaine (Erythroxylum coca) ● Taxol (Taxus sp.)
http://waynesword.palomar.edu/ww0703.htm http://en.wikipedia.org/wiki/Autonomic_nervous_system
Tobacco Nico ana tabacum
http://en.wikipedia.org/wiki/Autonomic_nervous_system
11 4/17/14
Fly agaric Amanita muscaria
http://en.wikipedia.org/nervous_system
Madagascar Curare periwinkle Chondrodendron Catharanthus roseus tomentosum
http://commons.wikimedia.org/wiki/ File:Starr_070906-8657_Catharanthus_roseus.jpg
http://www.cindysantiqueart.com/print-Chondrodendron
Tea Coffee Camellia sinensis Coffea arabica Cocoa Theobroma cacao
12 4/17/14
Jimson Weed Angels Trumpet Datura sp. Brugmansia sp. Opium poppy Papaver somniferum
http://www.aaronhuey.com/#/editorial-archive/afghanistan-drug-war/ Opium_032
Mandrake Coca Mandragora Erythroxylum coca officinarum
http://ignorf.net/what_is_a_mandrake.htm
Quinine Taxol Cinchona officinalis Taxus sp.
http://en.wikipedia.org/wiki/Cinchona http://commons.wikimedia.org/wiki/ File:Illustration_Taxus_baccata0.jpg
13 4/17/14
Holis c Medicine
Herbal Medicine
http://www.myballard.com/wp-content/uploads/health-fair.jpg
“Herb” Herbal History ● Plant, fungus, animal, or mineral ● Medicinal plant use predates recorded history ● Graves of Neanderthal: 60K y/o ● From gentle tonics to deadly toxins ● Oral transmission of knowledge
Herbal History Herbal History ● Sumerian drawings: 2500 B.P. ● Golden Age of Greece: 400 B.P. to 90 A.P. ● Tablets from Babylon empire: ~1700 B.P. ○ Aristotle (men ons henbane, licorice, and mint) ○ Theophrastus (first descrip on opium effects) ● Egyp ans: temple walls and Ebers Papyrus record ○ Hippocrates Dioscorides (De Materia Medica) over 700 medicinal formulas ○ Nicander (book of poisons)
14 4/17/14
Herbal History ● Middle ages: Monks compiled and copied Greek texts and local knowledge into herbals Persian Walnut ● Badianus manuscript ● Renaissance: Paracelsus rejected previous Juglans regia knowledge and invented his “doctrine of signatures”
http://en.wikipedia.org/wiki/File:Whole_Walnut_Kernel.jpg
“For the shaman or indigenous insider, a par cular plant’s Herbal History chemistry, phenology, community associates, habitat, uses, cultural value, mythic associa ons, growth curve, physical • Majority of discoveries from knowledge of rural- proper es and usual management come to mind in a living and indigenous peoples constella on of associated knowledge whenever the plant or its name is encountered in walking, thought, or conversa on.” • 19th century to present: Janis Alcorn p. 25. o crea on of drugs via extrac on Ethnobotany: o semi-synthesis of herbal compounds and Evolu on of a analogs Discipline
http://www.environmentalgraffiti.com/news-kayapo-people-get-helping-hand
Types of Herbalism Types of Herbalism ● Indigenous ● European ○ Most diverse ○ Roots from ancient Egyp an ○ Orally transmi ed via shamanic knowledge ○ Fer le Crescent ● Chinese (Wu-Sing) ○ Mediterranean civiliza ons ● Indian: Ayurveda (Hindu), Unani (Islamic) ● Neo-Western ● Japanese (Kampo) ○ Fuses Indigenous, European and Asian herbalism
15 4/17/14
http://djcadchina.wordpress.com/2012/02/page/16/
http://www.flickriver.com/photos/tags/unani/interesting/ http://nabatawy.blog.com/2010/04/09/egyptian-plants/
From Forest to Market ● Ethnobotany ○ Threatened cultures ○ Threatened species ■ Currently 5000X greater than natural rate ■ Climate change, pollu on, invasive species, habitat loss ■ Data: taxonomic, plant part, site, habitat, http://www.waltshealthfoods.com/products.html method of prepara on, etc.
16
4/17/14
Screening Programs ● Pharmacognosy ○ Study of physical, chemical, biochemical and biological proper es of drugs and search for drugs from natural substances ○ Screening programs ○ Separa on, iden fica on and ac vity: ■ Chromatography, Spectroscopy ■ Bioassays
http://faculty.sdmiramar.edu/fgarces/LabMatters/Instruments/Chromatography/ Chromatography.htm
Herbals in United States FDA Standards ● ~40% of Americans now use some form of ● Dietary Supplement Health and Educa on Act complementary and alterna ve medicine (CAM) (DSHEA) of 1994 ● ~5 billion dollars in revenue/year in US, ~60 billion
worldwide ● “Herbals” classified as supplements and foods ● Soaring healthcare costs, prophylac cs, last resort, ● No FDA approval needed before produc on and less invasive, less dangerous distribu on ● U.S. pts. fail to disclose use due to: HCP disinterest, ● Safe un l proven otherwise HCP nega ve response or lack of knowledge
17 4/17/14
FDA Standards FDA Standards ● Labeling: ● Good Manufacturing Prac ces (GMP) ○ Safety and truthfulness ● Europe ○ No known efficacy ○ Germany ○ Can discuss “structure func on claims” ■ Follows Commission E monographs (do not need extensive suppor ve evidence) ■ Rest of Europe following lead of Germany ● USP (US Pharmacopoeia) and NF (Na onal ● Asia Formulary): ○ Minimal regula ons ○ determine quality of herbals
Quality Issues ● Contamina on/Adultera on ○ Mistaken plants ○ Subs tu on of related species ○ Mycotoxins ○ Pes cides
Newmaster et al., 2013
Quality Issues ● Radioac ve ○ Cadmium ● Heavy metals ○ Lead ○ Arsenic (rice, fruits, vegetables) ○ Thallium ● Environmental pollu on Newmaster et al., 2013 ○ Salmonella
18 4/17/14
Clinical Issues Harvest, Storage, & Produc on ● Allergic reac ons ● Issues: ● Mutagenic effects ○ Gene c variability ● Drug-drug interac ons ○ Growth condi ons ● Contraindica ons: not enough data ○ Time of harvest ● Adverse/Side effects ○ Stage of growth ○ Length of storage ○ Storage condi ons ○ Binders, fillers used in packaging
Research Issues
● Plant misiden fica on ● Product contamina on 5 Herbs to Know ● Inadequate analyses for ac ve compounds ● Lack of pharmacokine c and pharmacodynamic informa on ● Need more prospec ve, randomized, placebo- controlled, blinded, and mul center studies
Black Cohosh Black Cohosh
● Actaea racemosa (Ranunculaceae)-ra le snake ● ADRs: root ○ Hepatotoxicity ● Taken for menopause symptoms and ○ GI irritability dysmenorrhea ○ Rash ● Efficacy not research supported ● Drug-drug interac ons ○ CYP 3A4 inhibi on ○ Chemotherapeu c agents
19 4/17/14
Acai
● Euterpe oleraceae (Arecaceae)-Acai berry ● Taken for HLD, allergies and cancer ● Moderate support for immune modula ng effects and providing protec on against ROS and inflamma on (high concentra on of anthocyanins)
http://williambritten.com/wordpress/wildflowers/smoky-mountains-wildflowers-black-cohosh/
Acai ● ADRs: ○ None known ● Drug-drug interac ons: ○ None known ● Precau ons: ○ Chagas disease
http://nutrivize.com/blog/general-health/acai-superfruit-or-superscam/
Ginkgo Ginkgo
● Ginkgo biloba (Ginkgoaceae)-fossil tree ● ADRs:
● Taken for infec on, cancer and cogni ve decline ○ Seizure
● Research is conflic ng in suppor ng its efficacy and ○ Spontaneous bleeding
the recent large GEM study does not support its ● Drug-drug interac ons
use in minimizing cogni ve decline ○ An -seizure agents ○ An coagulants/an platelets ○ MOAIs
20 4/17/14
Milk Thistle ● Silybum marianum (Asteraceae)-Holy thistle ● Taken for liver disease ● Research supports its effec veness in reducing aminotransferases in ETOH cirrhosis. Support for its use against other liver diseases is weak ● ADRs: Transamini s in high doses ● Drug-drug interac ons
http://fr.wikipedia.org/wiki/Ginkgo_biloba ○ strong CYP 3A4 inhibitor
St. Johns Wort ● Hypericum perforatum (Hypericaceae)-witches herb ● Taken for anxiety, depression, sleep and neuropathic pain ● Contraindica ons: ○ pregnancy ○ taking any other an depressants (serotonin syndrome) http://en.wikipedia.org/wiki/File:Milk_thistle_flowerhead.jpg
St. Johns Wort St. Johns Wort ● ADRs: ● Research supports its effec veness (as effec ve ○ photosensi vity as most SSRIs) against mild to moderate ○ N/V depression (reuptake inhibitor of serotonin, ○ GI irritability ○ coagulopathy norepinephrine and dopamine) ○ sexual dysfunc on ○ discon nua on syndrome ● Drug-drug interac ons ○ strong CYP 3A4 induc on and many other drugs!
21 4/17/14
Herbal Resources National Center for Complementary and http://nccam.nih.gov/health/ Alternative Medicine supplements.htn http://nccam.nih.gov/index.htm
Office of Dietary Supplements http://ods.od.nih.gov/
Natural Medicine Comprehensive www.naturaldatabase.com Database
Natural Standard www.naturalstandard.com
Consumer Labs http://www.consumerlab/results/index.asp
Memorial Sloan Kettering Center www.mskcc.org/aboutherbs Integrative Medicine Smart phone/Tablet application: About Herbs http://en.wikipedia.org/wiki/St_John's_wort
Herbal Resources Cochrane Library’s field group in http://www.cochranelibrary.com Medicinal Cannabis CAM website
Food and Drug Administration www.fda.gov/Food/ DietarySupplements/default.htm
MedWatch www.fda.gov/Safety/MedWatch/ default.htm
American Botanical Council http://www.herbmed.org/ http://www.herbalgram.org
US Pharmacopeia http://www.usp.org
http://www.thedailychronic.net/2013/18294/the-starbucks
History “Very few drugs, if any, have such a tangled history as a medicine. In fact, prejudice, ● Use started in Central Asia with proto-Indo supers on, emo onalism, and even ideology Europeans (Kurgans in ancient “Romania”) ● Later to West Asia (Scythians, Hebrews) and to have managed to lead cannabis to ups and India and China downs concerning both its therapeu c ● Chinese shamans; Chinese emperor Shen Nung proper es and its toxicological and dependence- prescribed 5k years ago inducing effects.” E. A. Carlini
22 4/17/14
History History ● Greeks (Hippocrates) , Romans (Galen), Norse ● Path towards illegal status ● India: Sadhus ○ Harry Anslinger and the Federal Bureau of ● Used as cura ve by Irish immigrants physicians in Narco cs: Reefer Madness and Marihuana Tax th late 19 century U.S of 1937 ● Before 1960s used mainly by European ○ Taken out of US pharmacopoeia and NF in 1941 st intellectuals, 1 genera on Hispanics and African ○ Outlawed in 1971 (Controlled Substance Act) Americans
Cannabis sa va
http://en.wikipedia.org/wiki/ http://www.photoburst.net/travel-photography/2013/05/babughat-kolkata File:Cannabis_sativa_Koehler_drawing.jpg
Hashish
Cannabis indica
http://ganjavibes.wordpress.com/tag/indica/
http://www.cannabissativa.com/cannabis/
23 4/17/14
Cannabinoids Cannabinoid Receptors
● ~70 phytocannabinoids ● Classical: ● Endogenous: ○ CB1-THC ○ Human receptor system-anandamide and 2- ● Nonclassical: AG ○ CB2: majority of other cannabinoids ● Synthe c
Synthe cs Extracts ● Dronabinol (Marinol): ● Nabiximols (Sa vex): ○ N/V for Ca chemo, appe te s mulant for AIDS ○ Mouth spray with 1:1 ra o of CB1:CB2 from cachexia cannabis ○ Schedule III ○ Europe and Canada only ● Nabilone (Cesamet): ○ In phase 3 trials in US: neuropathic pain
○ N/V, neuropathic pain, MS, fibromyalgia ● Epidiolex: ○ Cannabidiol extract for treatment of Lennox- ○ Schedule II: more potent than Marinol Gastaut syndrome(LGS)
Use Risks Use Risks ● Most widely used illicit drug in the world: over ● Cannabis dependence syndrome: 200 million regular users ○ psychological addic on (1 in 10 users) ● Cogni ve developmental delays if started before ○ IOM probability of dependence: age 18 and used chronically for ~10 years ■ MJ (9%) ● Increasing rates of THC: ■ ETOH (18%), ○ MJ: 5-35% ■ Cocaine (17%), ○ Hashish: 5-20% ■ Opiates (23%), ○ Hash oil: 15-60% ■ Nico ne (32%)
24 4/17/14
Use Risks Use Risks ● Same gateway drug risks as ETOH ● Lung cancer ● Idiosyncra c sensi vity to CB1 ● Chronic bronchi s with long term chronic use ● Contraindicated: Family hx or hx of personality ● Contaminants: disorders or psychosis ○ Aspergillus and bacteria ● Strict precau ons in: ○ Heavy metals ○ Pregnant of breast feeding women ○ Organophosphates ○ <18 y/o ○ Adulterants: PCP, cocaine, methamphetamine, ○ Elderly heroin, opium, seda ves, formalin ○ Substance abuse hx
Use Risks Use Benefits ● No toxic dose: ○ possible therapeu c ra o of 50K X (lithium and ● Neuropathic and Chronic pain digoxin 2-3 X) ● ALS/End of life ● Withdrawal symptoms: ● Decreases muscle spas city in MS ○ rela vely mild ● Levodopa induced dyskinesia in Parkinsons ● Minimal drug-drug interac ons: ○ CYP2C metabolism ● Criminal record and incarcera on
Use Benefits Use Benefits ● Cachexia ● PTSD ● Preliminary data: ■ IBS & IBD ● Tics in Toure e syndrome ■ Glaucoma ■ Migraines ● N/V ■ An epilep c ■ An cancer (CBD, CBG, CBGV) ■ Alzheimers ■ Fibromyalgia
25 4/17/14
Future Research Federal and State Law ● Schedule I drug: ● MDD ○ High abuse poten al, no medical use, lack of ● Demen a drugs accepted safety with MD supervision, other ● Bronchodilators drugs in this schedule: hallucinogens, heroin ● An allergen ● Schedule II: morphine, PCP, cocaine, methadone, ● An psycho cs methamphetamine
Federal and State Law Federal and State Law
● Many researchers and healthcare professionals in ● Benchmark data for schedule II approval exists: US reques ng Cannabis transfer to schedule II or ○ Therapeu c and pallia ve effects equivalent to allow access to schedule I for research other drugs ○ NAS, IOM, NIH, AMA, ACP vs. DEA, FDA, SAMHSA, NIDA ● Current state legisla on allows medicinal Cannabis for almost any indica on with minimal oversight
http://www.motherjones.com/politics/2014/02/pot-marijuana-legalization-map-states
http://psychotropia.co/?cat=12
26 4/17/14
Psychedelics History ● Shamanic divina on/ritual Sacraments: spiritual tools or sacred medicine by ○ Soma: proto-Indo Europeans non-Western cultures ○ S mulus for religion: vs. ■ Eleusinian Rites Dangerous drugs of abuse ● Ergot poisoning vs. ○ St. Anthony’s Fire Research and clinical tools for mental and physical ○ Salem Witch Trials disorders
History Main Groups Tryptamines LSD, Psilocybin, DMT, ● Psychotherapy Ibogaine
○ 20th century: un l 1971 ● Recrea onal Phenethylamines MDMA, Mescaline, Myristicin ○ S mulus of U.S. cultural revolu on Dissociative Ketamine, Phencyclidine hallucinogens (PCP), Ibogaine, Salvia
Main Groups Lysergic Acid Diethylamide (LSD) Other Ayahuasca, Fly agaric ● Ergot fungus (Claviceps purpurea ) ● Potent 5HT agonist 2A ● Colorless, odorless, tasteless and the most Pseudo-hallucinogen Cannabis potent drug known on the planet ○ 20 mcg can alter consciousness for 12 hours Anticholinergics Tropanes
27 4/17/14
Lysergic Acid Diethylamide (LSD)
● Avoid in pre-exis ng mental illness, par cularly schizophrenia ● Psychotherapy for anxiety based disorders Ergot fungus (mainly end of life (cancer)) and addic ons Claviceps purpurea ● Cluster headaches
http://en.wikipedia.org/wiki/Claviceps_purpurea
Psilocybin Psilocybe cubensis ● Converted to Psilocin in body ● Found in many species of mushrooms
● 5HT2A agonist ● Psychotherapy ○ OCD ○ End of life anxiety (cancer) ○ MDD ○ Nico ne addic on
● Cluster headaches http://divawhispers.com/onthescene/
N, N Dimethyltryptamine (DMT) ● Endogenous compound in humans ○ In near death experiences, DMT secreted from pineal gland ● Virola (Epena), Anadenanthera (Yopo), Psychotria, Bufo alvarius
● 5HT2A agonist ● Broken down by monoamine oxidases, so needs
MAOI adjunct or bypass MAOIs http://www.amazon-indians.org/yanomami.html
28 4/17/14
Ibogaine ● Tabernanthe iboga (Apocynaceae)
● 5HT2A agonist, NMDA receptor antagonist, kappa opioid receptor agonist ● Psychotherapy ○ An -addic on: ETOH, cocaine, opiates/opioids
Schultes et al., 1992
Mescaline ● From various species of cac
● 5HT2A agonist, adrenergic, dopaminergic ● Psychotherapy ○ Addic ons
Schultes et al., 1992
MDMA (Ecstasy) ● Synthesized from various plant precursors ● 5HT1A, 5HT1B, 5HT2A agonist, adrenergic, Peyote dopaminergic Lophophora ● Psychotherapy williamsii ○ PTSD ○ MDD (ECT replacement)
http://fineartamerica.com/featured/close-view-of-peyote-cacti-lophophorus-ira-block.html ○ Borderline personality disorder
29 4/17/14
Ayahuasca ● Mixture of two known hallucinogenic plants and many other admixture plants ● Bansteriopsis caapi: Beta carboline harmala alkaloids and MAOIs ● Psychotria viridis (Rubiaceae): DMT but needing MAOI to be ac vated orally ● Ayahuasca churches
http://www.redcloudindianarts.com/e-luna3.htm
Natural and Semi- Synthe c Legal Highs ● Natural: not yet on radar of public and legisla ve bodies ● Synthe c: The Controlled Substance Analogue Enforcement Act of 1986, tacked on to Controlled Substances Act of 1971: ○ chemical structure must be structurally similar
http://www.telegraph.co.uk/news/picturegalleries to other class I or IIs or acts same physiologically
Overdose Management Synthe c Cannabinoids ● Suppor ve therapy ● ‘Spice’ and many other common names ● BZDs: mainly A van ○ Compounds synthesized and sprayed on inert ● Restraints? plant material and sold as incense to bypass ● Lab and diagnos c tests: detec on or legal scru ny ○ CBC, CMP, Tox screen, Cardiac enzymes, ECG, ● Over 400 compounds from work of Dr. Huffman EEG (crea on of cannabinoids for research) ● 2nd most abused recrea onal drug behind Cannabis:
30 4/17/14
Synthe c Cannabinoids
● Can bypass drug tests: used by law, fire and armed forces ● Many mes more potent than hash oil ● Has been associated with psychosis, seizures, and MIs ● Treatment ○ BZDs and Trazodone http://winnipeg.ctvnews.ca/winnipeggers
Salvia Salvia ● Salvia divinorum (Lamiaceae) ● Used at greater rate than ecstasy in 18-24 y/o ● Ancient Mazatec herb for shamanic divina on ● Smoked ● Kappa opioid receptor agonist, dopaminergic ● Has been associated with anxiety and psychosis ● Kept from schedule I status: ● Treatment: ○ due to being promising candidate for novel ○ BZDs an depressant and non-addic ve analgesics and anesthe cs
Methedione/Methylone ● Synthe c deriva ves of Cathinone found in Khat (Catha edulis) ○ na ve to East Africa and Arabian peninsula and chewed for millennia for amphetamine-like quali es ● Known as “bath salts” ● Potent adrenergic and MAOI
http://en.wikipedia.org/wiki/File:Salvia_Divinorum ● Snorted and injected
31 4/17/14
Methedione/Methylone ● Causes: ○ agita on ○ seizures ○ excessive sympathomime c s mula on: ■ tachycardia, confusion, psychosis, hyponatremia ● Treatment
○ BZDs http://www.jewishjournal.com/world/article/widespread_khat_addiction_threatens_yemens_future
An cholinergics ● Datura, Brugmansia, Belladonna, Henbane ● Causes: ○ Tachycardia, HTN, restlessness, delirium, blurred vision ○ Hallucina ons: auditory, visual ● Treatment ○ Acetylcholinesterase inhibitor: ■ Physos gmine
http://fauxsociety.com/bath-salts-and-the-taste-for-flesh-zombie/
Cholinergics: Isoxazoles ● Occur in the genera: Clitocybe, Inocybe and in two species of Amanita ● Muscimol: GABA agonist, seratogenic, dopiminergic ● Ibotenic acid: NMDA agonist ● Fatali es rare but possible to die with inges on of 10 or more mushrooms ● Treatment: suppor ve
32 4/17/14
Other Legal Highs ● Kratom (Mitragyna speciosa) ○ Mitragynine: adrenerigic, mu and kappa opioid agonist, NMDA antagonist, seratonergic ● Morning glory (Ipomoea violacea) ○ LSA (d-lysergic acid amide): potent seratonergic
http://en.wikipedia.org/wiki/List_of_Amanita_species
Other Legal Highs ● Betel nut (Areca catechu) ○ Arecaidine and arecoline: adrenergic, GABA inhibitor, cholinergic agonist, highly carcinogenic ● Nutmeg (Myris ca fragrans) ○ Myris n (MAOI): adrenergic, dopiminergic, seratonergic
33 4/17/14
Herbal Poisons Herbal Poisons ● Acute management of poisoning ● Gastric decontamina on ○ Immediate stabiliza on, decontamina on, ○ Ipecac: no longer recommended exam and labs ○ Gastric lavage: no longer recommended ○ Pay close a en on to toxidrome, physical ○ Whole bowel irriga on: not recommended in and verbal evidence for source of poisoning herbal poisoning ○ Labs: CBC, CMP, UA, Coags, ECG, Cardiac ○ Charcoal: case by case basis, and only if can enzymes, ABGs, Tox screen, EEG be administered in first 1-2 hours of herbal inges on
Algae ● Pfiesteria piscicida (dinoflagellate): toxin 1000 mes stronger than cyanide, AKA “fish Ebola”, indirect toxicity via shellfish ● Signs and symptoms: fa gue, arthralgias, paresthesias, nausea, open sores, memory loss (las ng 1-2 weeks a er exposure), disorienta on ● Treatment ○ Suppor ve de.wikipedia.org/ wiki/Pfiesteria_piscicida
Pteridophytes ● Pteridium aquilinum: ○ Bracken fern ● Carcinogenic ptaquiloside and thiaminase: ○ neoplasms of the upper alimentary tract ●Found throughout east Texas and the mountains of west Texas ● Treatment: ○ Preven on
34 4/17/14
Gymnosperms Gymnosperms ● Cycadaceae: primarily Cycas revoluta (“Sago ● Texas ornamental palm”) in Texas. ● Signs and symptoms: ● Palm-like pinnate leaves, but dis nct cone-like ○ icterus, jaundice, N/V, liver failure, reproduc ve structures weakness, seizures ● Neurodegenera ve azoxy glycosides and ● Treatment: mutagenic cycasin ○ Suppor ve
Ephedra ● Ephedra sp. (join irs, ma huang, mormon tea) ○ thin ○ o en light green to blue ○ jointed stems with small cone-like reproduc ve structures ● Natural source of ephedrine and d- pseudoephedrine
Ephedra ● Distribu on is widespread in drier regions of the world, occurs in west Texas ● Signs and symptoms: ○ headache, diaphoresis, hyperthermia, MI/ Stroke, seizures, agita on ● Treatment: ○ BZDs http://commons.wikimedia.org/wiki/ File:Ephedra_fragilis_3.JPG
35 4/17/14
Araceae ● Araceae (Anthurium, Arisaema (Jack-in-the-pulpit), Arum (Lords and Ladies), Caladium, Colocasia, Angiosperms Dieffenbachia, Monstera, Alocasia, Philodendron) ● Raphides (cells) contain calcium oxalate crystals in Monocots the shape of needles and proteoly c enzymes in some genera ● Extremely diverse leaf morphology but generally similar reproduc ve structures (spathe and spadix)
Araceae ● Alocasia, Colocasia (Taro), and Xanthosoma eaten throughout Asia and South Pacific, some varie es with significant raphides ● Signs and symptoms: edema, erythema, bullae, altered speech, laryngeal occlusion ● Treatment: ○ Removal ○ An histamines
○ Steroids www.meemelink.com www.sarracenia.com/
Liliaceae ● Colchicum (Autumn crocus), Convallaria (Lily-of-the- valley), Gloriosa simplex (Gloriosa lily), Narcissus (daffodil, narcissus), Tulipa (tulip), Hymenocallis (spider lily), Amyrillis (naked ladies, etc.) ● Grass-like parallel veined leaves and trimerous (flower parts in threes), showy flowers; underground stems (e.g. bulbs and corms) ● A few uncommon na ve species, mainly ornamental
http://forums2.gardenweb.com/forums/load/houseplt genera are problema c
36 4/17/14
Liliaceae ● Toxins include: colchicine (highest in corms and seeds), lycorine, cardiac glycosides ● Signs and symptoms: fever, leukocytosis, palpita ons, dysrhythmias, shortness of breath, N/ V, abdominal pain, diarrhea, hematuria, dizziness, MODS ● Treatment: ○ Atropine ○ Fab fragment an gen binding
Solanaceae ● Atropa belladonna (deadly nightshade), Datura (jimsonweed), Hyoscamus (henbane), Lycopersicon Angiosperms esculentum (tomato), *Nico ana (tobacco), Solanum (black nightshade, horse ne le, potato, etc.), Dicots Brugmansia (angel trumpet) ● Diverse leave and stem morphology, flowers usually funnel-shaped and fused and fused stamens ● Toxic tropane alkaloids: hyoscyamine, atropine, scopolamine, solanine, cocaine
Solanaceae ● Na ve Solanum and Datura, others introduced or for food, smoke and ornamentals ● Signs and symptoms: dry mucous membranes, blurred vision, hyperthermia, HTN, tachycardia, ileus, urinary reten on, agita on, hallucina ons, delirium, seizures ● Treatment ○ Suppor ve ○ BZDs for cocaine ○ Physos gmine for tropanes
37 4/17/14
Schultes et al., 1992
Anacardiaceae ● Toxicodendron (radicans=poison ivy, diversilobium and quercifolium=western and eastern poison oak respec vely, vernix=poison sumac) Mangifera (mango), Anacardium (cashew) ● Small viny shrubs to tall trees, resinous leaves and bark, finely divided leaves (pinnately compound) ● Toxic compound: oleoresin (urushiol)
wikipedia/commons/a/a0/Illustration_Atropa
Anacardiaceae ● Signs and symptoms: type I hypersensi vity- extreme pruri s and pain, erythrema, vesicles- bullae ● Treatment: ○ removal: soap and water ○ an histamines ○ analgesics ○ Zanfel, calamine, oatmeal baths
○ Severe cases: systemic or topical steroids aloneonalimb.blogspot.com
38 4/17/14
aloneonalimb.blogspot.com
http://en.wikipedia.org/wiki/Cashew
Apocynaceae Apocynaceae ● Adenium (desert rose), Asclepias (milkweed), Nerium ● Asclepias represented in Texas; other genera listed (oleander), Theve a (yellow oleander), Catharanthus above grown as ornamentals roseus (rosy periwinkle) ● Signs and symptoms: anorexia, headache, ● Flowers o en fused as a tube and showy; all parts of photophobia, blurred vision, dysrhythmias, plant (flowers not always) exude white latex when dizziness, palpita ons, shortness of breath, MI/ torn or broken stroke, N/V, abdominal pain, seizures, delirium ● Cardiac glycosides ● Treatment: ○ Digitalis (digoxin and digitoxin) ○ Atropine ○ Liliaceae ○ Fab fragment an gen binding
39 4/17/14
http://commons.wikimedia.org/wiki/File:Starr_070906-8657_Catharanthus_roseus.jpg
Fabaceae ● Abrus precatorius (rosary pea), Acacia, Albizia, Astralagus (locoweeds), Erythrina (coral bean), Lupinus (bluebonnet, lupine), Physos gma (Calabar or ordeal bean), Sophora secundiflora (mescal bean, Texas mountain laurel), Wisteria ● Leaves o en pinnately compound, flowers showy, fruits are always legumes ● Cyanogenic glycosides, cys sine, physos gmine, quinolizidines, curare-like alkaloids, locaine, erythrane, http://www.taiwanplant.com/finishedplants_desert_rose.htm coralline
Fabaceae ● Many of these genera found growing in Texas either as endemics, ornamentals, or in an agricultural se ng ● Signs and symptoms: fever, blurred vision, diaphoresis, excessive saliva on, bradycardia, shortness of breath, bronchospasm, N/V, dizziness, muscle spasm, abnormal gait, seizures ● Treatment: ○ Suppor ve
40 4/17/14
http://www.erowid.org/
Euphorbiaceae ● Croton, Euphorbia, Manihot esculenta (cassava, yuca), Ricinis communis (castor bean) ● Cac -like, large trees to minute prostrate herbs, flowers with nectar glands, white latex with cellular damage ● Ricin, amygdalin and linamian=HCN, cytotoxic diterpenes ● Type I and IV hypersensi vity: latex an gens (prohevein), mostly from Rubber tree (Hevea brasiliensis)
Euphorbiaceae ● Signs and symptoms: ○ Ricin: resp. distress, hypotension, bloody urine and stool (36-72hrs un l death) ○ HCN: headache, blindness, deafness, dizziness, shortness of breath, N/V, diarrhea, inebria on, seizures, loss of sensorium
● Treatment: http://www.unitedfarmersassociation.com
○ HCN-hydroxocobalamin to form B12 (cyanobalamin), nitrites and thiosulfates ○ Ricin-Suppor ve
41 4/17/14
http://en.wikipedia.org/wiki/Castor_oil_plant
Apiaceae ● Aethusa spp. (fools parsley), Cicuta maculata (water hemlock), Conium maculatum (poison hemlock) ● Small to large herbs, the inflorescence of flowers arranged in an umbel ● Poisonous alkaloids, cicutoxin, coniine, resins; especially poisonous are leaves, unripe fruits and roots
http://www.myessentia.com/blog/why-natural-hevea-rubber-is- awesome/
Apiaceae ● Poison hemlock na ve to Texas, the rest are found elsewhere in N. America ● Phytophotoderma s: fucocoumarins ● Signs and symptoms: tachycardia to bradycardia, hypotension, N/V, abd pain, severe seizures, shock, coma, death ● Treatment: ○ Suppor ve
42 4/17/14
Others ● Rosaceae: ○ Prunus spp. (apricots, plums, bi er almonds, peach, and black cherry) and Pyrus spp. (pear) ○ Contain amygdalin which hydrolyzes into HCN ■ occurs in seeds, leaves, and bark, but most highly concentrated in seeds
http://www.skinps.com/blog/category/skin-conditions/
Others ● Order Ranunculales: ○ Includes Ranunculaceae and Papaveraceae ■ Acon um (monkshood), Anemone, Aquilegia (columbine), Argemone (prickly poppy), Clema s, Delphinium (larkspur), Papaver (poppies) ○ All of which mostly have toxic alkaloids
http://images.google.com/imgres?imgurl http://www.biology-blog.com/imag/columbine
43 4/17/14
http://www.burma-all.com/new%20burma http://ipcblog.org/2011/09/06/mother-natures-most-toxic/
Case Study ● 38 y/o female presen ng with N/V, severe abd. pain, cons pa on alterna ng with diarrhea; 6 similar episodes in last year all requiring ED visits, Mycotoxins only tramadol effec ve in pain management ● No PMH ● Lives on farm and all protein needs met from farm animals
Case Study Environmental/Food-related ● Repeatedly (-): CBC, CMP, amylase, lipase, abd. ● Aflatoxins US, stool exam with O&P, tTG, Hepa s A,B,C, ● Ochratoxin hCG, UA, FIT, ECG ● Citrinin ● Only significant findings: (+) ESR, colonoscopy: ● Patulin areas of inflamma on without any ulcera on ● Fusarium ● Subsequent inves ga on revealed highly elevated AFB1 levels in farm animals, strong evidence suppor ng aflatoxicosis as e ology
44 4/17/14
Case Study ● 55 y/o woman and her daughters collected wild mushrooms for soup and ate it with son and grandaughter ● Within 12 hours all experienced N/V, abd cramping, diarrhea ● All were treated for diarrhea with fluid resuscita on ● The children all died of fulminant hepa c and renal failure within the next few days ● The mother survived a er 4 weeks of intensive
http://en.wikipedia.org/wiki/File:Aspergillus_on_tomato.jpg suppor ve care
Cyclopep des ● Occur in the genus Amanita ● Amatoxin: alpha-amani n ● Inhibits protein synthesis in hepatocytes and causes nephrotoxicity ● Can not be deac vated by heat ● Cause ~90% of all fungi poisoning deaths and ~30% of individuals with cyclopep de poisoning
die http://en.wikipedia.org/wiki/Amanita_phalloides
Case Study Case Study ● 49 y/o Korean female presented to ED with GI ● Labs: LDH-243, Total bili-63 irritability and vomi ng, D/C a er symptoma c ● Symptoma c treatment and IV pyridoxine treatment, returned with interpreter next day to administered inform and give example of wild mushrooms ● For 4 more days: pt. with lethargy, abd. pain, ea n, pt with intense abd. pain, vomi ng and anorexia, N/V; Labs on day 5: LDH-693, AST-431, chills ALT-472 ● PE: vitals WNL, abd. tenderness, rare bowel ● Eventual full recovery sounds
45 4/17/14
-Hydrazine ● Occur in Gyromitra spp. (false morels) ● Monomethylhydrazine ● Can be inac vated with heat but vola liza on during cooking process can cause poisoning ● Similar to Isoniazid toxicity, as it causes B6 (pyridoxine) deple on which stops GABA synthesis ● Fatali es occur ~10% of the me
http://en.wikipedia.org/wiki/File:Frühjahrslorchel.JPG
Coprine ● Occur in Coprinus spp. (inky caps) ● Disulfirum-like reac on-hyperacetaldehydemia with ETOH ● Can not be inac vated with heat
http://www.mushroomexpert.com/images/kuo/coprinus_micaceus_06big.jpg
Orelline+Orellanine ● Occur in Cor narius spp. ● Disrupt the cytoskeleton and protein synthesis in renal tubular cells ● Can not be inac vated with heat
http://www.mushroomexpert.com/cortinarius_iodes.html
46 4/17/14
Herbals: Resources Resources Cannabis: Ashar, B., Rowland-Seymour, A. (2008). Advising pa ent who use dietary supplements. The American Journal of Medicine, 121(2), 91-97. Abrams, D., Jay, C. & Shade, S. (2007). Cannabis in painful HIV-associated sensory neuropathy: a randomized placebo controlled trial. Neurology, 68, 515-521. Chan, K. (2003). Some aspects of toxic contaminants in herbal medicines. Chemosphere, 52, 1361-1371. Alexander, A., Smith, P. & Rosengren. (2009). Cannabinoids in the treatment of cancer. Cancer Le ers, 285, 6-12.
Arseneault, L., Cannon, M., & Wi on, J. Causal associa on between Cannabis and psychosis: examina on of the evidence. Bri sh Journal of Davidson, E., Vlachojannis, J., Cameron, M. & Chrubasik, S. (2013). Best available evidence in Cochrane reviews on herbal medicine? Evidence-Based Complementary Psychiatry, 184, 110-117 and Alterna ve Medicine, 1-7. Baker, D., Pryce, G., & Croxford, J. (2000). Cannabinoids control spas city and tremor in mul ple sclerosis model. Nature, 404, 84-87. Elvin-Lewis, M. (2001). Should we be concerned about herbal remedies. Journal of Ethnopharmacology, 75, 141-164. Botswick, J. (2012). Blurred boundaries: the therapeu cs and poli cs of medical marijuana. Mayo Clinical Proceedings, 87(2), 172-186.
Lewis, W., & Elvin-Lewis, M. (2003). Medical Botany: Plants Affec ng Human Health. New York: John Wiley. Callaghan R, Allebeck P, Sidorchuk A. (2013). Marijuana use and risk of lung cancer: a 40-year cohort study. Cancer Causes Control, 10, 1811-1820.
Glisson, J. & Walker, L. (2010). How physicians should evaluate dietary supplements. The American Journal of Medicine, 123(7), 577-582. Croxford, L. & Yamamura, T. (2005). Cannabinoids and the immune system: Poten al for the treatment of inflammatory diseases? Journal of Neuroimmunology, 166, 3-18. Herbert-Ashton, M. (2002). Ge ng a handle on herbals. TNT, 16-23. Green, A., & De-Vries, K. (2010). Cannabis use in pallia ve care-an examina on of the evidence and the implica on for nurse. Journal of Clinical Nursing, 19, 2454-2462. Kahn, I. (2006). Issues related to botanicals. Life Sciences, 78, 2033-2038. Grotenhermen, F. & Muller-Vahl, K. (2012). The therapeu c poten al of Cannabis and Cannabinoids, Deutsches Ärztebla Interna onal. Park, B., Cho, J., Kim, Y., Ahn, Y., & Son, C. (2012). A prospec ve study on the safety of herbal medicines, used alone or with conven onal medicines. Journal of 109(29-30), 495-501. Ethnopharmocology, 143, 884-888. Hall, W., & Degenhardt, L. (2009). Adverse health effects of non-medical cannabis use. Lancet, 374, 1383-1391. Posadzki, P., Watson, L. & Ernst, E. (2013). Adverse effects of herbal medicines: an overview of systema c reviews. Clinical Medicine, 13(1), 7-12.
Tarn, D., Paterni , D., Good, J., Coulter, I., Galliher, J., Kravitz, R., Karlamangla, A. & Wenger, N. (2013). Physician-pa ent communica on about dietary supplements. Pa ent Educa on and Counseling, 91, 287-294.
Resources Resources Cannabis: Psychedelics: Holland, J. (2010). The Pot Book: A Complete Guide to Cannabis. Its Role in Medicine, Poli cs, Science, and Culture. Vermont, Park Street. Alper, K., Lotsof, H., Frenken, G., Luciano, D. & Bas aans. (1999). Treatment of acute opioid withdrawal with Ibogaine. The American Journal on Leung, L. (2011). Cannabis and its deriva ves: Review of medical use. JABFM, 24(4), 452-462. Addic ons, 8(3), 234-242. McLaren, J., Swi , W., Dillon, P. & Allsop, S. (2008). Cannabis potency and contamina on: a review of the literature. Addic on, 103, 1100-1109. Grob, C., Danforth, A., Chopra, G., Hagerty, M., McKay, C., Halberstadt, A., & Greer, G. (2011). Pilot study of Psilocybin treatment for anxiety in pa ents with advanced-stage cancer. Arch. Gen. Psychiatry, 68(1), 71-78. McQuay, H. (2010). More evidence Cannabis can help in neuropathic pain. CMAJ, 182(14), 1494-1495. Krebs, Teri & Johansen, P. (2012). Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials. Journal of Pletcher, M., Vi nghoff, E., Kalhan, R., Richman, J., Safford, M., Sidney, S., Lin, F., & Kertesz, S. (2012). Associa on between marijuana exposure and Psychopharmacology, 26(7), 994-1002. pulmonary func on over 20 years. JAMA, 307(2), 173-181. Nu , D. (2007). The development of a ra onal scale to assess the harm of drugs and poten al misuse. The Lancet, 369, 1047-1053. Rahavashisth, T., Shaheen, M., Norris, K., Pan, D., Sinha, S., Ortega, J., & Friedman, T. (2012). Decreased prevalence of diabetes in marijuana users: cross-sec onal data from the Na onal Health and Nutri on Examina on Survey (NHANES) III. BMJ Open, 2, 1-9. Preva -Smith, K. & Prisinzano, T. (2010). New therapeu c poten al for psychoac ve natural products. Natural Product Reports, 27, 23-31. Schreiner, A, Dunn M. (2012) Residual effects of cannabis use on neurocogni ve performance a er prolonged abs nence: a meta-analysis. Exp Clin Prisinzano, T. (2009). Natural products as tools for neuroscience: Discovery and development of novel agents to treat drug abuse. Journal of Psychpharmacol, 20,420-429. Natural Products, 72, 581-587. Sco , K., Shah, S., Dalgleish, A. & Liu, W. (2013) Enhancing the ac vity of Cannabidiol and other cannabinoids In vitro through modifica ons to drug Ross, S. (2011) Serotonergic hallucinogens and emerging targets for addic on pharmacotherapies. Psychiatr. Clin. N. Am., 35, 357-374. combina ons and treatment schedules. An cancer Research, 33(10), 4373-4380. Schultes, R., Hoffman, A. & Ratsch, C. (1992). Plants of the Gods. Their Sacred, Healing, and Hallucinogenic Powers. Vermont: Healing Arts. Tait, R, Mackinnon, A, Christensen H. (2011) Cannabis use and cogni ve func on: 8-year trajectory in a young adult cohort. Addic on, 106, Sessa, B. (2012). The Psychedelic Renaissance. London: Musmell Hill. 2195-2203. Sewell, R., Halpern, J. & Pope, H. (2006). Response of cluster headache to psilocybin and LSD. Neurology, 27(66), 1920-1922. Wilsey, B., Marco e, T., Deutsch, R., Gouaux, B., & Sakai, S. (2013). Low-dose vaporized Cannabis significantly improves neuropathic pain. The Journal of Pain, 14(2), 136-148.
Resources Resources Legal Highs: Poisonous herbals and management: Evren, C. & Bozkurt, M. (2013). Synthe c Cannabinoids: Crisis of the decade. The Journal Das, R., Parajuli, S., & Jayakumar, J. (2007). Last supper with mushroom soup: a case report of amatoxin poisoning. McGill Journal of Medicine, 10(2), 93-95. of Psychiatry and Neurological Sciences, 26, 1-11. Gresham, C., and Wilbeck, J. (2011). Toxicology in the emergency department: a review for the advanced prac ce nurse. Advanced Emergency Jerry, J., Collins, G., & Streem, D. (2012). Synthe c legal intoxica ng drugs: The emerging Nursing Journal, 34(1), 43-54. ‘incense’ and ‘bath salt’ phenomenon. Cleveland Clinic Journal of Medicine, 79(4), Leathem, A., Dorran, T. (2007). Poisoning due to raw Gyromitra esculenta (false morels) west of the Rockies. CJEM, 9(2), 127-130. 258-264. Lippinco ’s Manual of Toxicology. (2012). Lippinco , Williams & Wilcons.
Zawilska, J.B. (2011). “Legal highs”-New players in the old drama. Current drug abuse Lewis, W., & Elvin-Lewis, M. (2003). Medical Botany: Plants Affec ng Human Health. New York: John Wiley. reviews, 4, 122-130 Nelson, L., Lewin, N., Howland, M. Hoffman, R., Goldfrank, L. & Flomenbaun, N. (2010). Goldfrank’s Toxicologic Emergencies, 9th Ed. New York: McGraw-Hill
Perduri, R., Gobbs, S. (2009). Unexpected aflatoxin exposure in a women in Northern Italy: a case report. Cases Journal, 2, 7736.
47